Details for Patent: 8,759,372

« Back to Dashboard

Which drugs does patent 8,759,372 protect, and when does it expire?

Patent 8,759,372 protects NURTEC ODT and is included in one NDA.

This patent has forty-four patent family members in twenty-five countries.

Summary for Patent: 8,759,372

Title:	N-(5S,6S,9R)-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-ctclohepta[b]Pyridin-9-yl-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-carboxylate salt
Abstract:	Disclosed is a hemisulfate salt of Compound (I): and crystalline forms of the hemisulfate salt. Also disclosed are methods of using the hemisulfate salt of Compound (I) as a CGRP receptor antagonist, and pharmaceutical compositions comprising the hemisulfate salt of Compound (I). The hemisulfate salt of Compound (I) is useful in treating, preventing, or ameliorating disorders including migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases such as asthma, and chronic obstructive pulmonary disease (COPD).
Inventor(s):	Daniel Richard Roberts, Richard Raymond Schartman, Chenkou Wei
Assignee:	Bristol Myers Squibb Co
Application Number:	US13/775,528
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,759,372
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 8,759,372

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Pfizer	NURTEC ODT	rimegepant sulfate	TABLET, ORALLY DISINTEGRATING;ORAL	212728-001	Feb 27, 2020		RX	Yes	Yes			Y	Y

International Family Members for US Patent 8,759,372

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013226361
Brazil	112014021032
Canada	2865585